Anzeige
Mehr »
Login
Samstag, 26.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Warum diese Minenaktie Ihre beste Absicherung gegen wirtschaftliches Chaos sein könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
132 Leser
Artikel bewerten:
(0)

EvolutionIQ Expands MedHub: Active medical summarization transforming medical data into a competitive advantage

MedHub provides comprehensive medical synthesis that enables faster, smarter claims handling across lines of insurance

NEW YORK, Oct. 14, 2024 /PRNewswire/ -- EvolutionIQ, the market-leading Claims Guidance platform, today announced the expansion of MedHub to all life, health, accident, and casualty lines of insurance. MedHub is the only active medical summarization solution that transforms medical data into a competitive advantage by engaging claims professionals with holistic, tactical insights.

EvolutionIQ

Challenges in Existing Medical Summarization Tools

For every claim, claims handlers spend an average of 12.5 hours reviewing complex medical data from various sources, while managing increasingly overwhelming caseload volume. Claims professionals can spend days trying to decipher the case documents for a single claim, and medically-driven claims are only getting more complex.

Unfortunately, most medical summarization tools meant to ease this challenge rely on passive summary generation and rote risk reviews which, when overused, can erode claim professional proficiency.

EvolutionIQ's MedHub leverages EvolutionIQ's market-leading technology advantages in Claims Guidance and five years of experience putting tactical recommendations directly into the front lines of complex claim handling.

EvolutionIQ's advanced capabilities make medical insights highly interactive for claim professionals. With MedHub's adjuster-in-the-loop structure, the product ensures exceptionally useful summaries, clear claim synthesis, insights, and assessments while building claim handler proficiency.

This approach fosters critical thinking, deepens medical understanding, and leads to more informed decisions.

"MedHub enhances our claims professionals' ability to deeply understand their claimants' medical circumstances, and be a partner on their return to health journey. Using it inside our existing EvolutionIQ environment makes it a seamless expansion of our capabilities to better serve our claimants," said Amanda Staples, Vice President, Head of Group Insurance Claims, Prudential.

The MedHub Solution

MedHub seamlessly ingests, processes, and extracts data from hundreds of records, transforming dense, varied types of raw medical data and documentation into tactical insights. EvolutionIQ's solution enables claims professionals to make faster critical decisions through an adjuster-in-the-loop approach.

Claims professionals using MedHub explore medical timelines, uncover hidden connections, and engage with the raw medical data in a way that fosters true understanding and continues building medical proficiency. MedHub enables users to directly understand the records that generated the medical insights, with EvolutionIQ's Click for Evidence functionality taking users from synthesis to evidence with a click.

Carriers using MedHub benefit from:

Accelerated Reviews: Quickly extract critical information from hundreds of pages of medical records.

Enhanced Expertise: Engage your team with a deeper understanding of medical conditions and their impact on claims.

Exceptional Outcomes: Claims handlers make faster, more informed decisions, leading to improved customer experiences and reduced operational costs.

"The risk with any passive medical summary tool is it invites a copy/paste approach to time savings, and can potentially hurt claims outcomes," said Benjamin Berry, Chief Product Officer at EvolutionIQ. "MedHub is entirely different, actively engaging claims professionals in the medical synthesis itself with access to essential data, context, and a timeline for informed decision-making. MedHub's focus on expert engagement is a pivotal component in EvolutionIQ's vision to become the #1 trusted source of medical insights and analysis in the insurance industry."

With a lightweight design and configurable interface, MedHub can be enabled and operational for any insurance carrier within two weeks, post data onboarding.

About EvolutionIQ

EvolutionIQ pioneered Claims Guidance in 2019. Its explainable AI guides insurance claims professionals to their highest potential impact on claims, including specific Next Best Action guidance. EvolutionIQ improves the claimant experience and delivers better claim outcomes to claimants, carriers and their customers. EvolutionIQ serves the group disability, individual disability and workers' compensation markets worldwide. EvolutionIQ's AI native products have been adopted by 70% of the top 15 U.S. disability carriers and a growing list of workers' compensation carriers. The New York-based company employs almost 200 staff across the United States, Europe and Australia. For more information, visit evolutioniq.com and follow the company on LinkedIn.

Media Contact
Jason Kapler
Vice President of Marketing
EvolutionIQ
(917) 740-5608
Press@evolutioniq.com

Logo - https://mma.prnewswire.com/media/1723642/EvolutionIQ_updated_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/evolutioniq-expands-medhub-active-medical-summarization-transforming-medical-data-into-a-competitive-advantage-302275249.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.